Read more

October 21, 2022
3 min watch
Save

VIDEO: iStent infinite reduces IOP with lower medication burden

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — In this Healio Video Perspective from the AAO meeting, I. Paul Singh, MD, shares data about the Glaukos iStent infinite, designed to reduce IOP.

“Placing three iStents into the nasal angle 2 clock hours apart from each other, we found that we actually got 76% of patients with a 20% reduction of intraocular pressure with the same or less meds, an average about a 13% less medication burden,” Singh said. “Having access to these stents in a stand-alone population will change the paradigm over time.”